MEASUREMENT OF ERGOTAMINE IN HUMAN-PLASMA BY TRIPLE SECTOR QUADRUPOLE MASS-SPECTROMETRY WITH NEGATIVE-ION CHEMICAL IONIZATION

被引：12

作者：

HAERING, N

SETTLAGE, JA

SANDERS, SW

SCHUBERTH, R

机构：

[1] LAB GMBH & CO,BRUEHLWEG 23,D-7910 NEU ULM 4,FED REP GER

[2] FINNIGAN MAT,D-2088 BREMEN,FED REP GER

来源：

BIOMEDICAL MASS SPECTROMETRY | 1985年 / 12卷 / 05期

关键词：

D O I：

10.1002/bms.1200120503

中图分类号：

R318 [生物医学工程];

学科分类号：

0831 ;

摘要：

引用

页码：197 / 199

页数：3

共 12 条

[1] INVESTIGATION OF THE VENOCONSTRICTOR EFFECT OF 8' HYDROXYDIHYDROERGOTAMINE, THE MAIN METABOLITE OF DIHYDROERGOTAMINE, IN MAN [J].

AELLIG, WH .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 26 (02) :239-242

[2]

AYWARD M, 1983, CEPHALALGIA, V1, P146

[3] LOW ORAL BIOAVAILABILITY OF DIHYDROERGOTAMINE AND 1ST-PASS EXTRACTION IN PATIENTS WITH ORTHOSTATIC HYPOTENSION [J].

BOBIK, A ;

JENNINGS, G ;

SKEWS, H ;

ESLER, M ;

MCLEAN, A .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (05) :673-679

[4] DETERMINATION OF ERGOT ALKALOIDS IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND FLUORESCENCE DETECTION [J].

EDLUND, PO .

JOURNAL OF CHROMATOGRAPHY, 1981, 226 (01) :107-115

[5] LOW BIOAVAILABILITY OF ERGOTAMINE TARTRATE AFTER ORAL AND RECTAL ADMINISTRATION IN MIGRAINE SUFFERERS [J].

IBRAHEEM, JJ ;

PAALZOW, L ;

TFELTHANSEN, P .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 16 (06) :695-699

[6]

KIECHEL JR, 1979, J PHARMACOL-PARIS, V10, P533

[7]

KLEIMOLA TT, 1978, BR J CLIN PHARM, V1, P255

[8] BIOAVAILABILITY OF DIHYDROERGOTAMINE IN MAN [J].

LITTLE, PJ ;

JENNINGS, GL ;

SKEWS, H ;

BOBIK, A .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 13 (06) :785-790

[9]

MANSVELT FJW, 1978, J CHROMATOGR, V151, P113

[10] LOW BIOAVAILABILITY AS A CAUSE OF APPARENT FAILURE OF DIHYDROERGOTAMINE IN ORTHOSTATIC HYPOTENSION [J].

OLVER, IN ;

JENNINGS, GL ;

BOBIK, A ;

ESLER, M .

BRITISH MEDICAL JOURNAL, 1980, 281 (6235) :275-276

← 1 2 →